Pompholyx - I-Pompholyx
https://en.wikipedia.org/wiki/Dyshidrosis
☆ Emiphumeleni ka-2022 ye-Stiftung Warentest evela eJalimane, ukwaneliseka kwabathengi nge-ModelDerm bekungaphansi kancane kunokuxhumana okukhokhelwayo kwe-telemedicine. 

Kubonakala sengathi isilonda sesicishe saba ngcono.

Esigabeni esingamahlalakhona, i-scaly patch ingabonwa.
relevance score : -100.0%
References
Dyshidrotic Eczema: A Common Cause of Palmar Dermatitis 33173645 NIH
I- Dyshidrotic eczema , eyaziwa nangokuthi i-acute palmoplantar eczema, uhlobo oluvamile lwe-dermatitis yesandla kubantu abadala. Yenza cishe i-5-20% yezimo ze-hand dermatitis. Lesi simo sibonakala ngamabhamuza amancane agcwele uketshezi emaceleni eminwe nezintende zezandla, okubangelwa ukuvuvukala koqweqwe lwangaphandle lwesikhumba. Kwesinye isikhathi, lawa mabhamuza angahlangana akhe amakhudlwana, afana ne-'tapioca pudding'. Ezimweni ezimbi kakhulu, ukuqubuka kungasakazeka kuyo yonke intende yesandla. Ukuxilongwa ngokuvamile kusekelwe ekuhlolweni komtholampilo kokuqubuka okuphindelelayo okunamabhamuza avele kungazelelwe eminweni futhi asakazekele ezintendeni zezandla.
Dyshidrotic eczema (DE) or acute palmoplantar eczema is a common cause of hand dermatitis in adults. It accounts for 5-20% of the causes of DE. It is a vesiculobullous disorder of the hands and soles. It is an intraepidermal spongiosis of the thick epidermis in which accumulation of edema causes the formation of small, tense, clear, fluid-filled vesicles on the lateral aspects of the fingers that can become large and form bullae. The vesicles can have a deep-seated appearance, which is referred to as “tapioca pudding.” In severe cases, lesions can extend to the palmar area and affect the entire palmar aspect of the hand. The diagnosis is mostly clinical and suggested by a recurrent rash of acute onset with vesicles and bullae located in the fingers extending to the palmar surfaces of the hands.
Vesico-bullous rash caused by pompholyx eczema 22665876 NIH
Indoda eneminyaka engu-31 ubudala ivakashele umnyango wezifo zesikhumba inomlando wezinsuku ezi-4 wokuluma okukhulu, amabhamuza aqondile ezintendeni zezandla zombili. Ubesanda kuhlangana nomuntu onotwayi. Isiguli sasinomlando we-eczema nesifuba somoya kusukela ebuntwaneni kodwa sasingakaze sibe nokuqubuka ekukhuleni. Lapho kuhlolwa futhi kuhlaziywa nge-microscopic, amabhamuza abonwa ngaphandle kwezimpawu zokubhoboza, izibungu, noma amaqanda. Ukuxilongwa kokuqala kwe- pompholyx eczema kwenziwa, futhi isiguli saqala ukusebenzisa i-corticosteroids ye-topical ethambile. Kodwa-ke, isiguli sabuya ezinsukwini ezi-5 kamuva sinezimpawu eziya ziba zimbi kanye nokuqubuka okukhulu kwamabhamuza.
A 31-year-old man presented to dermatology with a 4 day history of an intensely itchy, linear, vesicular rash affecting the palms of both hands, on the background of recent exposure to a patient with scabies. The patient had a history of childhood eczema and asthma but no exacerbations in adulthood. Examination and microscopy revealed a vesicular rash with an absence of any burrows, mites or eggs. A provisional diagnosis of pompholyx eczema was made and the patient was commenced on mild topical corticosteroids. The patient re-presented 5 days later with worsening symptoms and a severe vesico-bullous rash
Ama-Allergens, ukucindezeleka ngokomzimba noma kwengqondo, ukugeza izandla njalo, noma izinsimbi kwenza lesi sifo sibe sibi kakhulu. Ukuxilongwa ngokuvamile kusekelwe kulokho okubukeka kanye nezimpawu. Ezinye izimo ezikhiqiza izimpawu ezifanayo zihlanganisa i-pustular psoriasis kanye notwayi.
Ukwelashwa ngokuvamile kwenziwa nge-steroid cream. Amandla aphezulu ama-steroid okhilimu angadingeka ngesonto lokuqala noma amabili. Ama-Antihistamine angase asetshenziswe ukusiza ngokulunywa.
○ Ukwelashwa - Izidakamizwa ze-OTC
Ungayisebenzisi insipho. Njengoba izintende nezinyawo zinesikhumba esiwugqinsi, amafutha e-OTC steroid anamandla aphansi angase angasebenzi. Ukuthatha i-OTC antihistamine nakho kungasiza.
#OTC steroid ointment
#OTC antihistamine
○ Ukwelashwa
#High potency steroid ointment
#Alitretinoin